Sarissa Capital Management »

Biohaven shares owned by Sarissa Capital Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Sarissa Capital Management from 13F filings

Historical chart of Sarissa Capital Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Sarissa Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.8M 513k 11.29

More positions owned by Sarissa Capital Management

Innoviva (INVA)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Neurocrine Biosciences (NBIX)
Cytokinetics Com New (CYTK)
Amarin Corp Sponsored Adr (AMRN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Biohaven (BHVN)
Regeneron Pharmaceuticals (REGN)
Vor Biopharma Com New (VOR)

View all positions for Sarissa Capital Management

Top funds holding Biohaven

Suvretta Capital Management
Stifel Financial
BlackRock
Henderson Group
Infinitum Asset Management
State Street Corporation
TCG Crossover Management
Vanguard Group
FMR
Geode Capital Management
Susquehanna International
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Caption Management
Schonfeld Strategic Advisors

View all funds holding Biohaven